Vertex Pharmaceuticals Inc
F:VX1
Wall Street
Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
VX1
is 426.12 EUR
with a low forecast of 288.88 EUR and a high forecast of 525.15 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VX1's stock price target?
Price Target
426.12
EUR
According to Wall Street analysts, the average 1-year price target for
VX1
is 426.12 EUR
with a low forecast of 288.88 EUR and a high forecast of 525.15 EUR.
What is Vertex Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Vertex Pharmaceuticals Inc's revenue is
17%.
The projected
CAGR
for the next 4 years is
10%.
What is Vertex Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
15%
For the last 13 years the
compound annual growth rate for
Vertex Pharmaceuticals Inc's operating income is
26%.
The projected
CAGR
for the next 4 years is
15%.
